CHARGED ALPHATMFrontier AI stock research

AXON · NasdaqGS

Axon Enterprise, Inc.

Aerospace & Defense · United States

USD 315.424.3% daily changeQuote 2026-11-11 · USD
Market cap (USD)
US$25.69B
Trailing P/E
101.42x
Forward P/E
33.40x
Quarterly revenue growth
27.9%
Trailing net margin
7.6%
Indicated dividend yield
—

Snapshot 2026-11-11 · Latest financial period 2026-09-30 · Yahoo Finance. Quotes may be delayed; reporting periods can differ.

Company background

Axon Enterprise, Inc. provides public safety technology solutions in the United States and internationally. The company operates in two segments, Software and Services, and Connected Devices. The Software and Services segment develops, manufactures, and sells cloud-based software-as-a-service solutions to capture, store, manage, share, and analyze video and other digital evidence. This segment also offers Axon Evidence, Draft One, Axon Records, Axon Standards, Axon Fusus, Axon Assistant, and others. The Connected Devices segment engages in the development, manufacture, and sale of integrated hardware solutions, such as conducted energy devices under the TASER brand, body cameras, fixed and in-car cameras, drone and counter-drone technologies, accessories, extended warranties, and related hardware products, as well as virtual reality training hardware. The company serves first responders across international, federal, state, and local governments, international governmental entities, commercial enterprises, and consumers through direct sales, distribution partners, and third-party resellers. The company was formerly known as TASER International, Inc. and changed its name to Axon Enterprise, Inc. in April 2017. Axon Enterprise, Inc. was incorporated in 1993 and is headquartered in Scottsdale, Arizona.

Company website

Q3 2026

Go beyond the headline.

AXON Stock: A $130M Delay Meets a $1.2B Drone Bet — Q3 2026

Published 2026-11-08

Q3 2026 REPORT HIGHLIGHTS

What’s changed for AXON

Software is accelerating, but federal timing, hardware margins and the Skydio funding commitment raise the cash hurdle; our updated base value is $310.

  1. The guidance cut is concentrated.

    Three Federal Dedrone deployments, totaling approximately $130M, leave the 2026 outlook. The filing supports a timing problem; it does not establish cancellation or a guaranteed recovery date.

  2. Software keeps gaining weight.

    Software & Services reached $437.0M, up 43.2%, contributing a computed two-thirds of the company’s incremental year-over-year revenue.

  3. Hardware growth carries a margin cost.

    Connected Devices gross margin fell to 43.0% from 49.9%; counter-drone mix, memory costs and new-product scaling matter alongside demand.

  4. Skydio expands the commitment before cash conversion is proven.

    Approximately $127.5M cash was paid at the November 5 primary closing; further tender and secondary investments remain conditional.

  5. The prior bearish operating tests largely triggered, yet valuation changed.

    Negative quarterly FCF and inventory above $550M confirm the old cautions. A much lower share price brings the updated $310 reference close to the market.

Comparable businesses

AXON peer comparison

Same business group first, then company size. Preferred market cap: 0.5–2x; extended range: one-third–3x. Outside that range, industry benchmarks are labeled separately and excluded from peer medians.

Comparison stocks

No suitable peers with fresh, comparable size data are available. We have not substituted unrelated companies.

Market metrics · missing or inapplicable values shown as —
MetricAXONAxon Enterprise, Inc.Snapshot 2026-11-11Financial period: 2026-09-30
Market capMarket value, converted to USDUS$25.69B
Forward P/EProvider forward earnings estimate33.40x
EV / EBITDAEnterprise value / trailing EBITDA147.94x
Revenue growthLatest quarter vs prior-year quarter27.9%
Operating marginLatest reported quarter1.5%
Free cash flow yieldTrailing cash flow / market cap0.3%
Net debt / EBITDANet debt / trailing EBITDA7.59x
Debt / equityTotal debt / positive book equity0.79x
Trailing P/ETrailing twelve-month earnings101.42x
Price / bookPrice / positive book equity per share6.82x
EV / salesEnterprise value / trailing revenue7.60x
Earnings growthLatest quarter vs prior-year quarter—
Gross marginTrailing twelve months57.3%
Net marginTrailing twelve months7.6%
Return on equityProvider trailing return; positive equity only7.6%
Free cash flow marginTrailing free cash flow / revenue1.9%
Dividend yieldIndicated annual dividend / price—
Earnings payoutProvider trailing dividend payout0.0%
Current ratioCurrent assets / current liabilities3.00x
BetaProvider historical market sensitivity1.47

Choose a comparison stock

Search covered companies, or search all listed stocks.

Comparison methodology & limitations

Reviewed operating groups override broad sector classifications. Other companies are matched only within a sufficiently specific provider industry. Business mix, geography and accounting standards can still differ. Market caps are converted to USD using exchange rates captured during the snapshot refresh. Financial ratios that would mix currencies are omitted. Snapshots must be at most 14 days old and no more than seven days apart for automatic selection.

Peer medians require at least two valid similar-size peers for each metric. Negative earnings, nonpositive equity, missing data and irrelevant bank ratios are not presented as attractive valuations. A higher or lower number is not automatically a better investment. Financial statement periods are not calendar-aligned across companies.

Reported performance

Financial trends

Reporting period
Financial history
Chart style
Comparison stocks

Financial statements load separately from the research page.

Market context

Valuation & price history

Adjusted closing price

Price history

Price history loads separately.

Earnings-multiple scenario

Illustrative price = your earnings-per-share assumption × your P/E assumption. This is not a price target or a complete valuation model.

Starting assumptions, when available, use provider forward estimates as of 2026-11-11. Negative earnings require a different valuation method. This calculation omits balance-sheet, dilution and execution risks.

THE RESEARCH RECORD

Research history for AXON

All available reporting periods
Q3 20262026-11-08
Q2 20262026-08-05
Q1 20262026-05-07

Reported figures

Verify material figures against company filings. Market data and AI-assisted analysis may contain errors.